19 min listen
Remdesivir and Dexamethasone for the Treatment of COVID-19
Remdesivir and Dexamethasone for the Treatment of COVID-19
ratings:
Length:
36 minutes
Released:
Jul 20, 2020
Format:
Podcast episode
Description
Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments. Related Article(s): Missed Opportunities on Emergency Remdesivir Use
Released:
Jul 20, 2020
Format:
Podcast episode
Titles in the series (100)
Prostate Cancer Screening: Edward H. Livingston MD, explores the topic of prostate cancer screening in author interviews with: Dan Merenstein about losing a case despite following evidence-based medicine guidelines (). Otis Brawley about . David... by JAMA Clinical Reviews